Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar
<h3>Background</h3><p dir="ltr">Adverse drug events (ADEs) resulting from nonoptimized medication therapy significantly drive-up healthcare costs. Clinical pharmacists are pivotal in managing medication regimens, effectively reducing these associated expenses.</p>&l...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513533592469504 |
|---|---|
| author | Daoud Al-Badriyeh (832403) |
| author2 | Shimaa Aboelbaha (16515288) Nurhan ElShafey (22504040) Moza Al Hail (2511859) Wessam El-Kassem (14829319) Palli Valapila Abdulrouf (11619462) Binny Thomas (5801969) Islam Eljilany (14151588) Noor Alsalemi (9107533) Mariyam Syed (22504043) Dina Abushanab (10696501) |
| author2_role | author author author author author author author author author author |
| author_facet | Daoud Al-Badriyeh (832403) Shimaa Aboelbaha (16515288) Nurhan ElShafey (22504040) Moza Al Hail (2511859) Wessam El-Kassem (14829319) Palli Valapila Abdulrouf (11619462) Binny Thomas (5801969) Islam Eljilany (14151588) Noor Alsalemi (9107533) Mariyam Syed (22504043) Dina Abushanab (10696501) |
| author_role | author |
| dc.creator.none.fl_str_mv | Daoud Al-Badriyeh (832403) Shimaa Aboelbaha (16515288) Nurhan ElShafey (22504040) Moza Al Hail (2511859) Wessam El-Kassem (14829319) Palli Valapila Abdulrouf (11619462) Binny Thomas (5801969) Islam Eljilany (14151588) Noor Alsalemi (9107533) Mariyam Syed (22504043) Dina Abushanab (10696501) |
| dc.date.none.fl_str_mv | 2025-06-07T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1007/s11096-025-01933-z |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Evaluating_the_economic_impact_of_clinical_pharmacist_interventions_in_the_women_s_health_setting_in_Qatar/30455795 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Pharmacology and pharmaceutical sciences Health sciences Public health Adverse drug events Clinical pharmacists Cost Economic impact Interventions Qatar Women’s health |
| dc.title.none.fl_str_mv | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Background</h3><p dir="ltr">Adverse drug events (ADEs) resulting from nonoptimized medication therapy significantly drive-up healthcare costs. Clinical pharmacists are pivotal in managing medication regimens, effectively reducing these associated expenses.</p><h3>Aim</h3><p dir="ltr">Given the scarcity of similar studies in the region, this study aimed to evaluate the overall economic impact of clinical pharmacists’ interventions against ADEs at the Women’s Wellness and Research Center (WWRC) in Qatar.</p><h3>Method</h3><p dir="ltr">Analysis of the total economic benefit of clinical pharmacists’ interventions was performed through a retrospective chart review of patients’ records admitted during the periods of March 2018, July–August 2018, and January 2019. The current analysis was based on WWRC’s perspective, in which the cost savings and cost avoidance associated with the interventions were used to determine the total economic benefit. A sensitivity analysis was conducted to determine the robustness of the results. The study was approved at the main public healthcare provider.</p><h3>Results</h3><p dir="ltr">A total of 331 interventions for 162 patients were included in the analysis. The total economic benefit was estimated to be QAR169,320 (USD46,503), comprising cost avoidance of QAR170,995 (USD46,964) and negative resource-use cost savings of QAR-1675 (USD-460). The increase in resource use was primarily due to the addition of other medications to therapy. The sensitivity analysis confirmed that the outcomes are robust, demonstrating a 100% probability for positive economic benefits in all simulated cases.</p><h3>Conclusion</h3><p dir="ltr">Although there was an observed increase in resource utilization resulting from clinical pharmacists’ interventions, this study highlights their crucial role in mitigating the costs associated with preventable adverse drug events.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Clinical Pharmacy<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s11096-025-01933-z" target="_blank">https://dx.doi.org/10.1007/s11096-025-01933-z</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_8e01079e10254acc074dcd894b10d7a2 |
| identifier_str_mv | 10.1007/s11096-025-01933-z |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/30455795 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in QatarDaoud Al-Badriyeh (832403)Shimaa Aboelbaha (16515288)Nurhan ElShafey (22504040)Moza Al Hail (2511859)Wessam El-Kassem (14829319)Palli Valapila Abdulrouf (11619462)Binny Thomas (5801969)Islam Eljilany (14151588)Noor Alsalemi (9107533)Mariyam Syed (22504043)Dina Abushanab (10696501)Biomedical and clinical sciencesPharmacology and pharmaceutical sciencesHealth sciencesPublic healthAdverse drug eventsClinical pharmacistsCostEconomic impactInterventionsQatarWomen’s health<h3>Background</h3><p dir="ltr">Adverse drug events (ADEs) resulting from nonoptimized medication therapy significantly drive-up healthcare costs. Clinical pharmacists are pivotal in managing medication regimens, effectively reducing these associated expenses.</p><h3>Aim</h3><p dir="ltr">Given the scarcity of similar studies in the region, this study aimed to evaluate the overall economic impact of clinical pharmacists’ interventions against ADEs at the Women’s Wellness and Research Center (WWRC) in Qatar.</p><h3>Method</h3><p dir="ltr">Analysis of the total economic benefit of clinical pharmacists’ interventions was performed through a retrospective chart review of patients’ records admitted during the periods of March 2018, July–August 2018, and January 2019. The current analysis was based on WWRC’s perspective, in which the cost savings and cost avoidance associated with the interventions were used to determine the total economic benefit. A sensitivity analysis was conducted to determine the robustness of the results. The study was approved at the main public healthcare provider.</p><h3>Results</h3><p dir="ltr">A total of 331 interventions for 162 patients were included in the analysis. The total economic benefit was estimated to be QAR169,320 (USD46,503), comprising cost avoidance of QAR170,995 (USD46,964) and negative resource-use cost savings of QAR-1675 (USD-460). The increase in resource use was primarily due to the addition of other medications to therapy. The sensitivity analysis confirmed that the outcomes are robust, demonstrating a 100% probability for positive economic benefits in all simulated cases.</p><h3>Conclusion</h3><p dir="ltr">Although there was an observed increase in resource utilization resulting from clinical pharmacists’ interventions, this study highlights their crucial role in mitigating the costs associated with preventable adverse drug events.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Clinical Pharmacy<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s11096-025-01933-z" target="_blank">https://dx.doi.org/10.1007/s11096-025-01933-z</a></p>2025-06-07T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s11096-025-01933-zhttps://figshare.com/articles/journal_contribution/Evaluating_the_economic_impact_of_clinical_pharmacist_interventions_in_the_women_s_health_setting_in_Qatar/30455795CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/304557952025-06-07T03:00:00Z |
| spellingShingle | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar Daoud Al-Badriyeh (832403) Biomedical and clinical sciences Pharmacology and pharmaceutical sciences Health sciences Public health Adverse drug events Clinical pharmacists Cost Economic impact Interventions Qatar Women’s health |
| status_str | publishedVersion |
| title | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| title_full | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| title_fullStr | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| title_full_unstemmed | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| title_short | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| title_sort | Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar |
| topic | Biomedical and clinical sciences Pharmacology and pharmaceutical sciences Health sciences Public health Adverse drug events Clinical pharmacists Cost Economic impact Interventions Qatar Women’s health |